Why IBD 50's No. 2 Stock, Travere Therapeutics, Has Doubled In 2025

BREAKING: Futures Rise After Bullish Market Move IBD Videos Get market updates, educational videos, webinars, and stock analysis. Get Started 11/18/2025Shares of Ligand Pharmaceuticals are absolutely flying as investors line... INVESTING RESOURCES Take a Trial Today Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20! Travere Therapeutics (TVTX) stock has more than doubled in 2025 even as competition heats up for its bread- and-but ...